Results 301 to 310 of about 17,850,454 (351)
Some of the next articles are maybe not open access.

Platelets and cardiovascular risk

Acta Cardiologica, 2017
Atherosclerosis and its late sequels are still the number one cause of death in Western societies. Platelets are a driving force not only during the genesis of atherosclerosis, but especially in its late stages, as evidenced by complications such as arterial thrombosis, myocardial infarction, and ischaemic stroke.
Barbara, Renga, Franco, Scavizzi
openaire   +2 more sources

Erythropoietin and Cardiovascular Risk

Blood Purification, 2008
We studied the changes in some cardiovascular risk (CVR) factors in 24 maintenance hemodialysis patients treated for 1 year with recombinant human erythropoietin (rHuEPO) either intravenously (12 cases) or subcutaneously (12 cases). In order to clarify whether changes in some parameters were due to direct action of rHuEPO or to changes in food intake ...
V, Allegra   +3 more
openaire   +2 more sources

NSAIDs and cardiovascular risk

Journal of Cardiovascular Medicine, 2017
NSAIDs are the most largely used class of drugs in the world, due to their large use in many diseases, in particular for the systemic inflammatory diseases. Nevertheless, today NSAIDs are less used for some of these diseases, due to several side-effects correlated to these drugs. The antiinflammatory mechanism of NSAIDs consist in the inibhition of two
Marsico F, Paolillo S, Filardi PP
openaire   +3 more sources

Albuminuria and cardiovascular risk

Hipertensión y Riesgo Vascular, 2023
Cardiovascular risk (CVR) estimation is a fundamental tool for guiding therapy. Albuminuria indicates target organ damage in an accessible, economic and non-invasive manner. Improves high-risk patient identification, especially in chronic kidney disease (CKD) and diabetes mellitus (DM). In addition, anti-albuminuric treatments may improve CVR.
D H, Rigo, P M, Jiménez, M, Orias
openaire   +2 more sources

Rosiglitazone and cardiovascular risk

Current Atherosclerosis Reports, 2008
A meta-analysis of 42 clinical trials suggested that rosiglitazone, a widely used thiazolidinedione, was associated with a 43% greater risk of myocardial infarction (P = 0.03) and a 64% greater risk of cardiovascular death (P = 0.06). However, a number of criticisms have been raised that potentially undermine the conclusions of this analysis.
Sanjay, Kaul, George A, Diamond
openaire   +3 more sources

Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association

Circulation, 2023
Cardiovascular-kidney-metabolic (CKM) syndrome is a novel construct recently defined by the American Heart Association in response to the high prevalence of metabolic and kidney disease.
Sadiya S. Khan   +14 more
semanticscholar   +1 more source

Hyperuricemia and cardiovascular risk

High Blood Pressure & Cardiovascular Prevention, 2014
There is an increasing prevalence of gout and hyperuricemia worldwide. Gout confers a significant individual and social burden and is increasingly recognized as a prevalent chronic disease state requiring appropriate long-term management. Gout and hyperuricemia appear to be independent risk factors for incident hypertension, renal disease and ...
Grassi D   +4 more
openaire   +4 more sources

Perioperative Cardiovascular Risk Assessment and Management for Noncardiac Surgery: A Review.

Journal of the American Medical Association (JAMA), 2020
Importance Perioperative cardiovascular complications occur in 3% of hospitalizations for noncardiac surgery in the US. This review summarizes evidence regarding cardiovascular risk assessment prior to noncardiac surgery.
N. Smilowitz, J. Berger
semanticscholar   +1 more source

Obesity and cardiovascular risk

Growth Hormone & IGF Research, 2003
In most industrialized countries, 40-60% of the population is now overweight or obese. Obesity has recently been recognized as a major modifiable risk factor for cardiovascular disease, second only to cigarette smoking. Excess weight and obesity markedly increase the risk for hypertension, diabetes, coronary artery disease and congestive heart failure ...
openaire   +2 more sources

Women and cardiovascular risk

The American Journal of Cardiology, 2001
Cardiovascular disease mortality rates have decreased in men during the past 20 years, but have steadily increased in women. In the United States, >500,000 women die of coronary artery disease (CAD) every year. Although many factors can influence an individual's risk for CAD, some factors are unique to women, including reproductive status. Menopause is
openaire   +2 more sources

Home - About - Disclaimer - Privacy